Press Releases :: Pieris Pharmaceuticals, Inc. (PIRS)

Sep 15, 2009 12:00am EDT

Pieris AG enters into Anticalin Collaboration with Allergan, Inc.

Feb 03, 2009 12:00am EST

Pieris reports development progress for Anticalin® PRS-050, a next generation VEGF antagonist

Jul 16, 2008 12:00am EDT

Wacker validates scalability of Anticalin® production with E.coli secretion technology and will produce Pieris first clinical candidate PRS-050

Mar 27, 2008 12:00am EDT

Pieris raises € 25 M (US$ 38 M) in Series B financing round

Nov 08, 2007 12:00am EST

Pieris strengthens its management, as it prepares for the clinical development of PRS-050, an Anticalin®-based novel cancer therapy

Oct 30, 2007 12:00am EDT

Pieris and Pepscan to identify GPCR-specific Anticalins® using CLIPS™ protein mimicry technology

Sep 05, 2007 12:00am EDT

Pieris validates the use of Anticalins® as ophthalmologic biotherapeutics

Jul 10, 2007 12:00am EDT

Pieris progresses proprietary asthma program: validation of pulmonary delivery of Anticalin®-based protein product candidate

Jun 21, 2007 12:00am EDT

Pieris progresses development of its proprietary biotherapeutics platform: successful demonstration of dual targeting with Duocalin® technology

Mar 29, 2007 12:00am EDT

Pieris Demonstrates Potent Anti-Tumor Activity of a VEGF-Specific Anticalin® in Preclinical Studies

Previous
1…
17
18
19
20
21
22
23
24
25
26